The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie.

AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...

Crain's residential real estate reporter Dennis Rodkin and host Amy Guth discuss the latest from the local housing market.

A newly available 31-acre corporate campus in Lincolnshire is a premier opportunity for businesses seeking state-of-the-art facilities in one of the Chicago area’s prime corporate corridors. “For ...

Trump calls for API stockpile, OCOchem to scale up chemicals from carbon dioxide, Covestro to buy isocyanates plants, and ...

President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...